Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays / Chiara Gabbiani;Guido Mastrobuoni;Francesca Sorrentino;Barbara Dani;Maria Pia Rigobello;Alberto Bindoli;Maria Agostina Cinellu;Giuseppe Pieraccini;Luigi Messori;Angela Casini. - In: MEDCHEMCOMM. - ISSN 2040-2503. - STAMPA. - 2:(2011), pp. 50-54. [10.1039/c0md00181c]
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(iii) compounds studied with combined mass spectrometry and biochemical assays
MESSORI, LUIGI;
2011
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
